N Chiba

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi request reprint A Canadian physician survey of dyspepsia management
    N Chiba
    Surrey GI Clinic, Guelph, Ontario
    Can J Gastroenterol 12:83-90. 1998
  2. pmc Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies
    N Chiba
    Division of Gastroenterology at McMaster University in Hamilton, Ont, Surrey GI Clinic, Guelph, ON
    Can Fam Physician 44:1481-8. 1998
  3. ncbi request reprint Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori
    N Chiba
    Surrey GI Clinic, Guelph, Canada
    Can J Gastroenterol 14:27-31. 2000
  4. ncbi request reprint From bench to bedside to bug: an update of clinically relevant advances in the care of persons with Helicobacter pylori- associated diseases
    N Chiba
    Surrey GI Clinic, Guelph, Ontario, Canada
    Can J Gastroenterol 14:188-98. 2000
  5. ncbi request reprint Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study
    D Armstrong
    Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada
    Aliment Pharmacol Ther 21:1189-202. 2005
  6. ncbi request reprint Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia
    N Chiba
    Surrey GI Clinic Research, Guelph, Ontario, Canada
    Aliment Pharmacol Ther 19:349-58. 2004
  7. ncbi request reprint Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens
    N Chiba
    Surrey GI Clinic Research, Guelph, Ontario, Canada
    Can J Gastroenterol 14:885-9. 2000
  8. ncbi request reprint Ranitidine bismuth citrate
    N Chiba
    Surrey GI Clinic/Research, Guelph, Ontario, Canada
    Can J Gastroenterol 15:389-98. 2001
  9. ncbi request reprint Validation of a symptom diary for patients with gastro-oesophageal reflux disease
    M A Puhan
    Horten Centre, University of Zurich, Switzerland
    Aliment Pharmacol Ther 23:531-41. 2006
  10. ncbi request reprint Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, NS, Canada
    Aliment Pharmacol Ther 23:521-9. 2006

Detail Information

Publications15

  1. ncbi request reprint A Canadian physician survey of dyspepsia management
    N Chiba
    Surrey GI Clinic, Guelph, Ontario
    Can J Gastroenterol 12:83-90. 1998
    ..To determine the management of patients with new onset dyspepsia by Canadian family physicians...
  2. pmc Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies
    N Chiba
    Division of Gastroenterology at McMaster University in Hamilton, Ont, Surrey GI Clinic, Guelph, ON
    Can Fam Physician 44:1481-8. 1998
    ..To review current evidence for primary care physicians who manage Helicobacter pylori in peptic ulcer disease...
  3. ncbi request reprint Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori
    N Chiba
    Surrey GI Clinic, Guelph, Canada
    Can J Gastroenterol 14:27-31. 2000
    ..Triple therapy for one week with omeprazole, clarithromycin and metronidazole (OCM) is accepted worldwide as a first line therapy for Helicobacter pylori eradication. It is unclear whether omeprazole needs to be given once or twice daily...
  4. ncbi request reprint From bench to bedside to bug: an update of clinically relevant advances in the care of persons with Helicobacter pylori- associated diseases
    N Chiba
    Surrey GI Clinic, Guelph, Ontario, Canada
    Can J Gastroenterol 14:188-98. 2000
    ..pylori infection. The number of H pylori-associated gastroduodenal diseases grows to include possible liver, vascular, immune and skin conditions...
  5. ncbi request reprint Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study
    D Armstrong
    Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada
    Aliment Pharmacol Ther 21:1189-202. 2005
    ..There are few data on empiric, stepped therapy for heartburn relief or subsequent relapse in primary care...
  6. ncbi request reprint Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia
    N Chiba
    Surrey GI Clinic Research, Guelph, Ontario, Canada
    Aliment Pharmacol Ther 19:349-58. 2004
    ..omeprazole and placebo antimicrobials (OPP) in the Canadian Adult Dyspepsia Empiric Treatment-H. pylori-positive (CADET-Hp) study...
  7. ncbi request reprint Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens
    N Chiba
    Surrey GI Clinic Research, Guelph, Ontario, Canada
    Can J Gastroenterol 14:885-9. 2000
    ..With the growing emergence of H pylori resistance to metronidazole and clarithromycin, further research to clarify the role of bismuth compounds is required...
  8. ncbi request reprint Ranitidine bismuth citrate
    N Chiba
    Surrey GI Clinic/Research, Guelph, Ontario, Canada
    Can J Gastroenterol 15:389-98. 2001
    ..RBC, used alone or in combination with other antibiotics, appears to be a safe and effective drug for the treatment of H pylori infection. Bismuth levels do not appear to rise to toxic levels...
  9. ncbi request reprint Validation of a symptom diary for patients with gastro-oesophageal reflux disease
    M A Puhan
    Horten Centre, University of Zurich, Switzerland
    Aliment Pharmacol Ther 23:531-41. 2006
    ..We assessed the validity and responsiveness of a symptom diary for patients with gastro-oesophageal reflux disease...
  10. ncbi request reprint Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, NS, Canada
    Aliment Pharmacol Ther 23:521-9. 2006
    ..Currently there is no consensus on the optimal method to measure the severity of dyspepsia symptoms in clinical trials...
  11. ncbi request reprint The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy
    S J O Veldhuyzen van Zanten
    Division of Gastroenterology, Dalhousie University, Halifax, NS, Canada
    Aliment Pharmacol Ther 23:595-9. 2006
    ..The prevalence of Barrett's oesophagus in patients undergoing gastroscopy may be influenced by possible referral bias...
  12. ncbi request reprint Do physicians correctly assess patient symptom severity in gastro-oesophageal reflux disease?
    C A Fallone
    Division of Gastroenterology, McGill University Health Center, Montreal, QC, Canada
    Aliment Pharmacol Ther 20:1161-9. 2004
    ..The accuracy of physicians' assessment of the severity of gastro-oesophageal reflux disease is unclear...
  13. ncbi request reprint The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study
    A B R Thomson
    University of Alberta, Edmonton, Alberta, Canada
    Aliment Pharmacol Ther 17:1481-91. 2003
    ..Uninvestigated dyspepsia is common in family practice. The prevalence of clinically significant upper gastrointestinal findings (CSFs) in adult uninvestigated dyspepsia patients, and their predictability based on history, is unknown...
  14. ncbi request reprint Gastric acid secretory response in Helicobacter pylori-positive patients with duodenal ulcer disease
    K Jacobson
    Department of Medicine, McMaster University Medical Centre, Hamilton, Canada
    Can J Gastroenterol 15:29-39. 2001
    ....
  15. pmc Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension
    T Chiba
    Department of Ophthalmology, University of Yamanashi Faculty of Medicine, 1110 Shimokato, Tamaho, Yamanashi 409 3898, Japan
    Br J Ophthalmol 90:314-7. 2006
    ..To investigate the effects of a non-steroidal anti-inflammatory drug (NSAID) ophthalmic solution on latanoprost induced intraocular pressure (IOP) reduction in glaucoma patients...